Toumaz (TMZ)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | n/a |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 1.53 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Dec | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | TTM | 2012E | 2013E | CAGR / Avg | |
| Revenue | £m | ||||||||||
| Operating Profit | £m | ||||||||||
| Net Profit | £m | ||||||||||
| EPS Reported | p | ||||||||||
| EPS Normalised | p | ||||||||||
| EPS Growth | % | ||||||||||
| PE Ratio | x | ||||||||||
| PEG | x | ||||||||||
| Profitability | |||||||||||
| Operating Margin | % | ||||||||||
| ROA | % | ||||||||||
| ROCE | % | ||||||||||
| ROE | % | ||||||||||
| Cashflow | |||||||||||
| Op. Cashflow ps | p | ||||||||||
| Capex ps | p | ||||||||||
| Free Cashflow ps | p | ||||||||||
| Dividends | |||||||||||
| Dividend ps | p | ||||||||||
| Dividend Growth | % | ||||||||||
| Dividend Yield | % | ||||||||||
| Dividend Cover | x | ||||||||||
| Balance Sheet | |||||||||||
| Cash etc | £m | ||||||||||
| Working Capital | £m | ||||||||||
| Net Fixed Assets | £m | ||||||||||
| Net Debt | £m | ||||||||||
| Book Value | £m | ||||||||||
| Average Shares | m | ||||||||||
| Book Value ps | p | -18.4% | |||||||||
FINANCIAL BRIEF: For the six months ended 30 June 2012, Toumaz Ld revenues increased 23% to L846K. Net loss increased 37% to L4.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items remained flat at -L0.01. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 30th Jun '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 0 | 0 | 0 | 0 | 1 |
Toumaz Limited, formerly Toumaz Holdings Limited, is engaged in the commercial exploitation of ultra-low power wireless infrastructure technologies with commercial propositions for the Toumaz Healthcare Limited (Toumaz Healthcare) and Toumaz Microsystems Limited (Toumaz Microsystems) divisions. Toumaz UK covers health technology solutions, and Toumaz Microsystems covers the design and development of semiconductor chips and solutions for low power wireless communication. Its Toumaz Microsystems business designs, develops and sells semiconductor chips and solutions for the wireless connectivity market, addressing opportunities in a range of Internet connected devices. These include home and enterprise automation, smart power, intelligent toys and other connectivity-centric cloud-enabled systems. In March 2012, it completed the exchange of Imagination Technologies Group plc's interest in its Toumaz Microsystems subsidiary. In August 2012, it acquired Frontier Silicon (Holdings) Limited.
Directors: Christofer Toumazou (Chmn.) , Anthony Sethill (CEO) 51, Jonathan Apps (CFO) 48,
No. of Employees: 78 No. of Shareholders: n/a
| Last Annual | December 31st, 2011 |
| Last Interim | June 30th, 2012 |
| Shares in Issue | 1,132,512,797 |
| Free Float | 1.01bn (89.4%) |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | FTSE Aim All Share, |
| Exchange |
London Stock Exchange (AIM) |
| Eligible for | an ISA? a SIPP? |
| Address | Walker House Mary Street,P O Box 265GT, GEORGE TOWN, Cayman Islands |
| Web | http://www.toumazltd.com/ |
| Phone | +44 78 6250474 |
| Contact | Richard Rose (Investor Relations) |
| Registrar | Capita Registrars (Jersey) Limited |
| Auditors | Grant Thornton UK LLP |
| Wed 11:45am | Issue of Shares |
| Tue 3:15pm | Notice of AGM |
| 8th May | Issue of Equity |
| 30th Apr | Issue of Equity |
| 25th Apr | Results of SensiumVitals pilot |
| 25th Apr | Full Year Results |
Recent ↓
